Cargando…
Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
Although the prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, evidence-based therapies for HFpEF remain limited, likely due to an incomplete understanding of this disease. This study sought to identify the cardiac-specific features of protein and phosphoprotein cha...
Autores principales: | Valero-Muñoz, María, Saw, Eng Leng, Hekman, Ryan M., Blum, Benjamin C., Hourani, Zaynab, Granzier, Henk, Emili, Andrew, Sam, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452734/ https://www.ncbi.nlm.nih.gov/pubmed/36093146 http://dx.doi.org/10.3389/fcvm.2022.966968 |
Ejemplares similares
-
Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
por: Singh, Ajmer, et al.
Publicado: (2018) -
Tubulin expression and modification in heart failure with preserved ejection fraction (HFpEF)
por: Schulz, Lisa, et al.
Publicado: (2022) -
Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Jyotsna, FNU, et al.
Publicado: (2023) -
OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
por: Almeida-Coelho, João, et al.
Publicado: (2022) -
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)